Identification of a compound heterozygous missense mutation in LAMA2 gene from a patient with merosin‐deficient congenital muscular dystrophy type 1A
Open Access
- 16 September 2021
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 35 (11) , e23930
Abstract
Background: Merosin‐deficient congenital muscular dystrophy type 1A (MDC1A) is occurred by mutations in LAMA2 gene that encodes the laminin α2 chain (merosin). MDC1A is a predominant subtype of congenital muscular dystrophy. Herein, we identified two missense mutations in LAMA2 gene in compound heterozygous status in an Iranian patient with MDC1A using whole‐exome sequencing (WES).Methods: In the present study, we evaluated genetic alterations in an Iranian 35‐month‐old boy with MDC1A and his healthy family using WES method. The identified mutations further confirmed by Sanger sequencing method. Finally, in silico analysis was conducted to further evaluation of molecular function of the identified genetic variants.Results: We identified two potentially pathogenic missense mutations in compound heterozygous state (c.7681G>A p.Gly2561Ser and c.4840A>G p.Asn1614Asp) in LAMA2 gene as contributing to the MDC1A phenotype. The healthy parents of our proband are single heterozygous for identified mutations. These variants were found to be pathogenic by in silico analysis.Conclusions: In general, we successfully identified LAMA2 gene mutations in an Iranian patient with MDC1A using WES. The identified mutations in LAMA2 gene can be useful in genetic counseling, prenatal diagnosis, and predicting prognosis of MDC1A.Keywords
This publication has 23 references indexed in Scilit:
- Merosin-deficient congenital muscular dystrophy: A novel homozygous mutation in the laminin-2 geneJournal of Clinical Neuroscience, 2015
- Current strategies for mutation detection in phenotype-driven screens utilising next generation sequencingMammalian Genome, 2015
- Targeted Next Generation Sequencing Identifies a Novel Deletion in LAMA2 Gene in a Merosin Deficient Congenital Muscular Dystrophy PatientIndian Journal of Pediatrics, 2015
- Prevalence of congenital muscular dystrophy in ItalyNeurology, 2015
- The Extracellular Matrix Protein Laminin α2 Regulates the Maturation and Function of the Blood–Brain BarrierJournal of Neuroscience, 2014
- High creatine kinase levels and white matter changes: Clinical and genetic spectrum of congenital muscular dystrophies with laminin alpha-2 deficiencyMolecular and Cellular Probes, 2014
- Diagnostic approach to the congenital muscular dystrophiesNeuromuscular Disorders, 2014
- Genotype/phenotype analysis in Chinese laminin‐α2 deficient congenital muscular dystrophy patientsClinical Genetics, 2014
- Laminin-211 in skeletal muscle functionCell Adhesion & Migration, 2013
- Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategiesSkeletal Muscle, 2011